About FDA

Percentage of INAD study submissions reviewed within the month that were acted on within 180 days after the submission date

Dictionary: Sponsors may submit data intended to support an application for new animal drug approval during the investigation of the new animal drug to an INAD file. A study submission is a submission containing both the data and conclusions of a study to be considered in support of the approval of a new animal drug. This measure assesses ONADE's timely review and decision making on one aspect of a new animal drug application. (1)

Information is current as of November 30, 2012.

• FY 2010
• FY 2011
• FY 2012
• FY 2013
• All

Footnotes

• (1) This metric is also an Animal Drug User Fee Program performance goal. In the yearly performance report to Congress, performance is reported for a defined fiscal year receipt cohort. The methodology for reporting by fiscal year receipt cohort calculates performance statistics for submissions for the fiscal year FDA received them, regardless of when FDA ultimately acted on or approved the submissions. The data reported here is the measurement of the number of applications reviewed in a given month regardless of the cohort year.

Number of INAD study submissions reviewed within the month that were acted upon within 180 days after the submission date

Fiscal Year - 2013

Time	Fiscal Year Target	Number
Oct 2012	N/A	24
Nov 2012	N/A	20
Dec 2012	N/A	TBD
Jan 2013	N/A	TBD
Feb 2013	N/A	TBD
Mar 2013	N/A	TBD
Apr 2013	N/A	TBD
May 2013	N/A	TBD
Jun 2013	N/A	TBD
Jul 2013	N/A	TBD
Aug 2013	N/A	TBD
Sep 2013	N/A	TBD

FY 2013 YTD: 44

Number of INAD study submissions reviewed and acted on within the month

Fiscal Year - 2013

Time	Fiscal Year Target	Number
Oct 2012	N/A	24
Nov 2012	N/A	20
Dec 2012	N/A	TBD
Jan 2013	N/A	TBD
Feb 2013	N/A	TBD
Mar 2013	N/A	TBD
Apr 2013	N/A	TBD
May 2013	N/A	TBD
Jun 2013	N/A	TBD
Jul 2013	N/A	TBD
Aug 2013	N/A	TBD
Sep 2013	N/A	TBD

FY 2013 YTD: 44